New Systemic Agents and Strategies in the Management of Breast Cancer is a unique continuing medical education activity that attempts to review key clinical questions regarding the integration of newly FDA-approved therapies in breast cancer into oncology practice. Featuring commentary from Drs Howard Burris and Joyce O’Shaughnessy.
